Stem Cells

Scientists reverse brain cell aging

Researchers tackle 'brain stiffness' with a soft touch approach that could see a cure for Alzheimer's. As we age, our brain tissue becomes progressively stiffer...

Pharma giant Bayer grabs Longevity lifeline

Full acquisition of BlueRock Therapeutics signals ever-deepening commitment to cellular replacement therapies but, as Monsanto settlement looms, it's unlikely to smooth the bumpy road...

California’s leading stem cell institute announces $5.5 billion bid for survival

The CIRM’s funding has all but dried up, but will voters throw it a lifeline or send it packing? "There is no money available for...

Bio-ink breakthrough allows for 3D printing

Researchers create stem cell ‘bio-ink’ that they hope will be used for regenerative medicine, drug screening and the study of developmental biology. Longevity.Technology: Even if...

Latest articles

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.